Sign in to view content

Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa: Results from the Phase 2b Trial

Anthony Joseph, MD

Video
Published 2020

Related

One Year Follow-Up in a Phase ½ Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa
Benjamin Bakall, MD, PhD
Updates from the Field
2024
Four-Headed Retinal Surgical Monster: RP + ERM + FTMH + RD
Christopher G Fuller, MD
Innovative Retina Surgical Video Series
2014
Analysis of Emergent Non-Hospital Based Retina Consultation Requests in an Academic Non-Hospital Associated Retina Practice
Barton L Blackorby, MD
Annual Meeting Talks
2020

Category: Hereditary Retinal Disease & Genetics

See more